Dublin, Ireland, June 21, 2022 (GLOBE NEWSWIRE) -- As per a recent report published by Fact.MR, the global oligonucleotide synthesis market is poised to grow at a CAGR of 11.3% from 2022 to 2032. During the said forecast period, the industry is expected to close at a valuation of US$ 17 Billion. Oligonucleotides have enormous latent applications in curing an extensive array of medical conditions. They allow the expansion of therapeutics as the crashing genes can be targeted, manipulated, silenced, and/or modulated.
From 2015 to 2021, the market for oligonucleotide synthesis grew at a CAGR of 16.3%, closing at a value of US$ 988 Million. As of 2022, the industry is likely to reach US$ 5.7 Billion. Pharmaceutical companies are concentrating on oligonucleotides as therapeutic agents such as antisense and RNAi therapeutics in the U.S region. These companies are making hefty investments in molecular diagnostics and clinical applications.
“The global oligonucleotide synthesis market exhibits an upward trend. As the nature of health problems becomes complicated with each passing day, demand for more robust and state-of-the-art treatment facilities is increasing. Considering the existing scenario, key market players are concentrating on introducing pathways in synthetic chemistry,” comments a Fact.MR analyst.
For more insights into the Market, Get A Sample of this Report!
https://www.factmr.com/connectus/sample?flag=S&rep_id=4853
Key Takeaways from the Market Study
- Global oligonucleotide synthesis market to treble from 2022-2032
- Synthesized oligonucleotide synthesis to be a top-selling category, capturing more than 3/5th revenue and flourishing at a 12.2% CAGR
- By application, oligonucleotide synthesis for the therapeutics to expand at a CAGR of 18.4%
- U.S to emerge as the fastest-growing Oligonucleotide Synthesis market, documenting a 10.2% CAGR
- APAC to be the 2nd most opportunistic market, expected to be valued at US$ 1.7 Billion in 2032
Competitive Landscape
The global market for Oligonucleotide Synthesis is characterized by the presence of multiple vendors, aiming to offer extensive consulting and integration services to clients. Additionally, enterprises are seeking out, specialized service providers, offering solutions tailor-made to suit their business objectives. In addition, the vendors are likely to leverage up-gradation and product differentiation to gain an edge over other competitors in the market.
- In Jan 2021, Thermo Fisher Scientific Inc., the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences industry announced that Thermo Fisher has completed the acquisition of Henogen S.A., Novasep’s viral vector manufacturing business in Belgium for approximately 725 Mn Euro in cash.
- In June 2019, CordenPharma International and GE Healthcare’s Dharmacon Business have entered a strategic collaboration to create an end-to-end solution for oligonucleotide-based drug discovery. The collaboration addressed the speed and capacity challenges researchers face when transitioning from research and preclinical stages to drug development and clinical trials.
For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4853
Key Segments Covered in the Oligonucleotide Synthesis Industry Survey
- Oligonucleotide Synthesis by Product :
- Oligonucleotide Synthesis Reagents & Consumables
- Oligonucleotide Synthesis Equipment
- Synthesized Oligonucleotides:
- DNA Oligonucleotides
- RNA Oligonucleotides
- Other Oligonucleotide Synthesis Products
- Oligonucleotide Synthesis by Application :
- Oligonucleotide Synthesis for Research
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing
- Others
- Oligonucleotide Synthesis for Therapeutics
- Antisense Oligonucleotides
- Nucleic Acid Aptamers
- Oligonucleotide Synthesis for Diagnostics
- Oligonucleotide Synthesis for Research
- Oligonucleotide Synthesis by End User :
- Oligonucleotide Synthesis Products for Biotechnology & Pharmaceutical Companies
- Oligonucleotide Synthesis Products for Research Institutes
- Oligonucleotide Synthesis Products for Diagnostic Laboratories
- Oligonucleotide Synthesis by Region :
- North America Oligonucleotide Synthesis Market
- Latin America Oligonucleotide Synthesis Market
- Europe Oligonucleotide Synthesis Market
- Asia Pacific Oligonucleotide Synthesis Market
- Middle East & Africa Oligonucleotide Synthesis Market
More Valuable Insights
Fact.MR, in its new offering, presents an unbiased analysis of the global Oligonucleotide Synthesis market, presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032.
The study reveals essential insights on the basis of product (reagents & consumables, equipment, synthesized oligonucleotides, DNA oligonucleotides, RNA oligonucleotides and others), application (research and therapeutics) and end user (biotechnology & pharmaceutical companies, research institutes and diagnostic laboratories) across five major regions (North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa).
Get Customization on this Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4853
Fact.MR’s Domain Knowledge in Healthcare
Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support – encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.
Explore More Healthcare Industry Reports:
Intrapartum Monitoring Devices Market Outlook (2022-2032) - The global intrapartum monitoring devices market was valued at US$ 2.2 Billion in 2021, and is projected to register a Y-o-Y increase of 4.5% in 2022 to be valued at US$ 2.3 Billion.
Europe Patient Positioning System Market Outlook (2022-2032) - The Europe patient positioning system market is currently valued at US$ 287.5 million and is projected to register 4.5% CAGR through 2032.
Global Mobile Imaging Services Market Outlook - The mobile imaging services market is predicted to grow at a steady CAGR of 3.9% during the projected period of 2022 to 2032. The mobile imaging services market share is estimated to be worth more than US$ 2.7 Billion by 2032
U.S. Patient Positioning System Market Outlook (2022-2032) - Patient positioning system sales in the United States are estimated to cross a market valuation of US$ 324.8 million by the end of 2032. The U.S. patient positioning system market is forecasted to expand at 4.3% CAGR over the 2022-2032
Global Mixed Mode Chromatography Resin Market Outlook - The mixed mode chromatography resin market is predicted to grow at an impressive CAGR of 15.7% during the forecast period covering 2022 to 2032.
Idiopathic Thrombocytopenic Purpura Therapeutics Market Outlook (2022-2032) - The global idiopathic thrombocytopenic purpura therapeutics market was valued at US$ 587.0 Million in 2021, and is projected to be valued at US$ 620.5 Million in 2022. During the 2022-2032 period of assessment, demand is expected to rise at a 5.0% value CAGR.
Global Medical Nonwoven Disposables Market Outlook 2022 to 2032 - The medical nonwoven disposables market is predicted to grow at a moderate CAGR of 3.5% during the forecast period covering 2022 to 2032.
Global Contrast Media Injectors Market Outlook (2022-2032) - With a Y-o-Y growth rate of 7.1%, the global contrast media injectors market is estimated at US$ 1.5 Billion in 2022, as against US$ 1.4 Billion in 2021. With the growing prevalence of cancer and rising investments, the market is expected to garner US$ 3.1 Billion in 2032, reflecting a CAGR of 7.4% from 2022 to 2032.
Global Fixed and Mobile C-Arms Market Outlook - The fixed and mobile c-arms market is predicted to grow at a steady CAGR of 4.3% during the projected period of 2022 to 2032. The fixed and mobile c-arms share is estimated to be worth more than US$ 4.8 Billion by 2032.
Collateral Ligament Stabilizer System Market Snapshot - The global collateral ligament stabilizer system market was valued at US$ 1.8 Billion in 2021, and is projected to register a Y-o-Y increase of 6.6% in 2022 to be valued at US$ 1.9 Billion.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-1583
